Autoimmune thyroiditis — what is new? DOI Creative Commons
Maria Kazakova, A. A. Tskaeva, E. A. Starostina

и другие.

Clinical and experimental thyroidology, Год журнала: 2024, Номер 19(4), С. 4 - 12

Опубликована: Июнь 11, 2024

Recently, the prevalence of autoimmune diseases has been steadily increasing among population, posing a significant problem for healthcare. One most common pathologies is thyroiditis (AIT). Due to absence prognostic markers predict outcomes AIT, such as development hypothyroidism, there an necessity molecular-genetic research into changes occurring within this disease. This likely contribute new diagnostic methods and identification key aspects pathogenesis, thereby preventing process. area includes analyzing impact environmental factors on Investigating relationships between stages AIT pathogenesis can form basis aimed at modifying these prevent disease progression. Studying comorbidity various thyroid different etiologies, helps identify high-risk groups subsequent screening early detection. Thus, exploring molecular-biological lays foundation developing effective strategies in prevention, diagnosis, therapy, improving quality life patients.

Язык: Английский

Evaluation of thyroid dysfunction in childhood-onset systemic lupus erythematosus: Risk factors for Hashimoto’s thyroiditis DOI
Elif Kılıç Könte, Hasan Karakaş, Nergis Akay

и другие.

Lupus, Год журнала: 2024, Номер 33(11), С. 1235 - 1241

Опубликована: Авг. 9, 2024

Objective Increased frequency of autoimmune thyroid disease, particularly Hashimoto’s thyroiditis (HT) was reported several studies in the literature, individuals with childhood-onset systemic lupus erythematosus (cSLE). Our study aimed to investigate prevalence and contributing factors dysfunction HT among cSLE patients. Methods Thyroid function tests were obtained cross-sectionally from Demographic, clinical, laboratory characteristics activity scores collected medical records. Patients diagnosed compared healthy control group for dysfunction. The Mann-Whitney U, independent samples t test, Chi-square or Fisher’s exact test used compare groups. A p-value below 0.05 considered statistically significant. Results Out 73 patients, 14 (19.1%) had subclinical hypothyroidism, 9 (12.3%) clinical 12 (16.4%) HT, a family history HT. USG performed 5 euthyroid patients 1 borderline hypothyroid patient positive autoantibody as diffuse heterogeneous echogenicity enlargement gland. There no significant differences data medication between groups without HT; however, higher hypothyroidism Cumulative prednisolone dose significantly lower considerably group. Conclusion results demonstrate an increased incidence even if they are euthyroid, recommend that be screened more frequently.

Язык: Английский

Процитировано

1

Autoimmune thyroiditis — what is new? DOI Creative Commons
Maria Kazakova, A. A. Tskaeva, E. A. Starostina

и другие.

Clinical and experimental thyroidology, Год журнала: 2024, Номер 19(4), С. 4 - 12

Опубликована: Июнь 11, 2024

Recently, the prevalence of autoimmune diseases has been steadily increasing among population, posing a significant problem for healthcare. One most common pathologies is thyroiditis (AIT). Due to absence prognostic markers predict outcomes AIT, such as development hypothyroidism, there an necessity molecular-genetic research into changes occurring within this disease. This likely contribute new diagnostic methods and identification key aspects pathogenesis, thereby preventing process. area includes analyzing impact environmental factors on Investigating relationships between stages AIT pathogenesis can form basis aimed at modifying these prevent disease progression. Studying comorbidity various thyroid different etiologies, helps identify high-risk groups subsequent screening early detection. Thus, exploring molecular-biological lays foundation developing effective strategies in prevention, diagnosis, therapy, improving quality life patients.

Язык: Английский

Процитировано

0